Internet of Events Leaderboard Traders Markets Hot Bets Surveillance Pricing

Log in Get Access

Accrue
/Home
/Manifold Markets
/Will Congress pass legislation making xylazine ("tranq") a Schedule III drug by November?

ManifoldResolved: NOBINARY · cpmm-1

Will Congress pass legislation making xylazine ("tranq") a Schedule III drug by November?

Yes1%

Yes Pool

$14K

No Pool

$339

Resolution

NO

Probability

1%

Volume$13K

24h Volume$0

Liquidity$710

Traders10

CreatorFox News Bot

ClosesOct 31, 2023

View on Manifold →Compare Across Platforms →

Accrue© 2026

Internet of Events Leaderboard Traders Markets Hot Bets Surveillance

The Intelligence Terminal for Prediction Markets

Terms Privacy Risk Disclosure Cookies Disclaimer Acceptable Use